Corporate news - Gerresheimer

公司新闻

Dividend of EUR 1.25 per share after strong financial year 2022 High approval rates for all agenda items Forecast reaffirmed: double-digit growth…
阅读更多
3.14 million new shares placed at EUR 86.50 with gross proceeds of EUR 271.6 million Strong investor demand underlines support for formula G…
阅读更多
Duesseldorf, April 18, 2023 – Today, the management board of Gerresheimer AG (ISIN DE000A0LD6E6), with the approval of the supervisory board, resolved…
阅读更多
First-quarter revenues grew organically by 21.0% Adjusted EBITDA up organically by 24.8% Gerresheimer confirms guidance for financial year 2023  …
阅读更多
Gerresheimer AG, Duesseldorf, invites tenders for the mandate to audit the Annual Financial Statements and Consolidated Financial Statements as well…
阅读更多
Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022 Organic growth…
阅读更多
Düsseldorf, Germany, February 8, 2023. Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma,…
阅读更多
– Top rating recognizes commitment to creating a positive impact on climate change Duesseldorf, January 19th 2023 – Gerresheimer AG, a leading…
阅读更多
Strong order intake in all areas with increasing revenue share of biological solutions and injectables New platform wins reinforce position as…
阅读更多

联系我们!

您有什么问题吗?
我们很乐意帮助您!

邮箱: info-china
电话:186 6119 5281 (微信同号)

留言

工作机会